-
1
-
-
0029049553
-
A candidate genetic risk factor for vascular disease: A common mutation in methylenetetrahydrofolate reductase
-
(1995)
Nature Genet
, vol.10
, pp. 111-113
-
-
Frosst, P.1
Blom, H.J.2
Milos, R.3
Goyette, P.4
Sheppard, C.A.5
Matthews, R.G.6
Boers, G.J.7
Den Heijer, M.8
Kluijtmans, L.A.9
Van den Heuvel, L.P.10
-
2
-
-
0030027668
-
Relation between folate status, a common mutation in the methylenetetrahydrofolate reductase and plasma homocysteine concentration
-
(1996)
Circulation
, vol.93
, pp. 7-9
-
-
Jacques, P.F.1
Bostom, A.G.2
William, R.R.3
Ellison, R.C.4
Eckfeldt, J.H.5
Rosenberg, I.H.6
Selhub, J.7
Rozen, R.8
-
5
-
-
0030762686
-
Hyperhomocysteinemia in end-stage renal disease: Prevalence, etiology, and potential relationship to arteriosclerotic outcomes
-
(1997)
Kidney Int
, vol.52
, pp. 10-20
-
-
Bostom, A.G.1
Lathrop, L.2
-
6
-
-
0028966321
-
Association between plasma homocysteine concentration and extracranial carotid artery stenosis
-
(1995)
N Engl J Med
, vol.332
, pp. 286-291
-
-
Selhub, J.1
Jacques, P.F.2
Bostom, A.G.3
D'Agostino, R.B.4
Wilson, W.5
Belinger, A.J.6
O'Leary, D.H.7
Wolf, P.A.8
Schaefer, E.J.9
Rosenberg, I.H.10
-
8
-
-
0033609464
-
Determinants of fasting plasma total homocysteine levels among chronic stable renal transplantation
-
(1999)
Transplantation
, vol.68
, pp. 257-261
-
-
Bostom, A.G.1
Gohh, R.Y.2
Beaulieu, A.J.3
Han, H.4
Jacques, P.F.5
Selhub, J.6
Dworkin, L.7
Rosenberg, I.H.8
-
13
-
-
10544252271
-
Hyperhomocysteinemia confers an independent increased risk factor of atherosclerosis in end-stage renal disease and is closely related to plasma folate and pyridoxine concentrations
-
(1996)
Circulation
, vol.94
, pp. 2743-2748
-
-
Robinson, K.1
Gutpa, A.2
Dennis, V.3
Arheart, K.4
Chaudhary, D.5
Green, R.6
Vigo, P.7
Mayer, E.L.8
Selhub, J.9
Kutner, M.10
Jacobsen, D.W.11
-
14
-
-
0031914677
-
Prospective study of hyperhomocystemia as an adverse cardiovascular risk factor in end-stage renal disease
-
(1998)
Circulation
, vol.97
, pp. 138-141
-
-
Moustapha, A.1
Naso, A.2
Nahlaoui, M.3
Gupta, A.4
Arheart, E.D.5
Jacobsen, D.W.6
Robinson, K.7
Dennis, V.W.8
-
16
-
-
0028987132
-
Hyperhomocysteinemia and traditional cardiovascular risk factors in end-stage renal disease patients on dialysis: A case-control study
-
(1995)
Atherosclerosis
, vol.114
, pp. 93-103
-
-
Bostom, A.G.1
Shemin, D.2
Lapane, K.L.3
Miller, J.W.4
Sutherland, P.5
Nadeau, M.6
Seyoum, E.7
Hartman, W.8
Prior, R.9
Wilson, P.W.F.10
Selhub, J.11
-
18
-
-
7144226583
-
Major determinants of hyperhomocysteinemia in peritoneal dialysis
-
(1998)
Kidney Int
, vol.53
, pp. 1775-1782
-
-
Vychytil, A.1
Fodinger, M.2
Wolfl, G.3
Enzenberger, B.4
Auinger, M.5
Prischl, F.6
Buxbaum, M.7
Wiesholzer, M.8
Mannhalter, C.9
Horl, W.H.10
Sunder-Plassmann, G.11
-
23
-
-
0029885203
-
Folate status is the major determinant of fasting total plasma homocysteine levels in maintenance dialysis patients
-
(1996)
Atherosclerosis
, vol.123
, pp. 193-202
-
-
Bostom, A.G.1
Shemin, D.2
Lapane, K.L.3
Nadeau, M.R.4
Sutherland, P.5
Chan, J.6
Rozen, R.7
Yoburn, D.8
Jacques, P.F.9
Selhub, J.10
Rosenberg, I.H.11
-
25
-
-
0030060126
-
High dose B vitamin treatment of hyperhomocysteinemia in dialysis patients
-
(1996)
Kidney Int
, vol.49
, pp. 147-152
-
-
Bostom, A.G.1
Shemin, D.2
Laplane, K.L.3
Hume, A.L.4
Yoburn, D.5
Nadeau, M.R.6
Bendich, A.7
Selhub, J.8
Rosenberg, I.H.9
-
26
-
-
0030851289
-
Mutation (677 C to T) in the methylenetetrahydrofolate reductase gene aggravates hyperhomocysteinemia in hemodialysis patients
-
(1997)
Kidney Int
, vol.52
, pp. 517-523
-
-
Fodinger, M.1
Mannhalter, C.2
Wolfl, G.3
Pabinger, I.4
Muller, E.5
Schmid, R.6
Horl, W.L.7
Sunder-Plassmann, G.8
|